Home / Congress Presentations / IC-MPGN and C3G / Banff Foundation for Allograft Pathology and Paris Institute for Transplantation and Organ Regeneration (Banff-PITOR) 2024
Landing
Banff Foundation for Allograft Pathology and Paris Institute for Transplantation and Organ Regeneration (Banff-PITOR) 2024
Pegcetacoplan for post-transplant recurrent C3G or IC-MPGN in NOBLE: 12-week evolution
Pegcetacoplan maintains early improvements in post-transplant recurrent C3G and IC-MPGN: 1-year results from the phase 2 NOBLE trial
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.